BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25576930)

  • 21. How does Mycobacterium leprae target the peripheral nervous system?
    Rambukkana A
    Trends Microbiol; 2000 Jan; 8(1):23-8. PubMed ID: 10637640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host parasite response in nerve in leprosy.
    Turk JL
    Indian J Lepr; 1996; 68(1):113-7. PubMed ID: 8727123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
    Andrade PR; Jardim MR; da Silva AC; Manhaes PS; Antunes SL; Vital R; Prata RB; Petito RB; Pinheiro RO; Sarno EN
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):272-83. PubMed ID: 26888306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice.
    Ebenezer GJ; Arumugam S; Job CK
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):245-9. PubMed ID: 12768925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell and Mycobacterium leprae in experimental leprosy.
    Kumar R; Vaidya MC
    Hansenol Int; 1982 Jun; 7(1):1-7. PubMed ID: 6764919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periodic acid-ethanol gelatin methenamine silver stain for demonstrating M. leprae and myelin in peripheral nerve fibers of leprosy patients.
    Harada K; Suzuki K
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):84-7. PubMed ID: 2423620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of functional candidates amongst hypothetical proteins of Mycobacterium leprae Br4923, a causative agent of leprosy.
    Naqvi AA; Ahmad F; Hassan MI
    Genome; 2015 Jan; 58(1):25-42. PubMed ID: 25985983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light and ultrastructural study of sciatic nerve lesions induced using intraneural injection of viable Mycobacterium leprae in normal and immunosuppressed Swiss white mice.
    Shetty VP; Antia NH
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):25-33. PubMed ID: 12120037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usage of signaling in neurodegeneration and regeneration of peripheral nerves by leprosy bacteria.
    Rambukkana A
    Prog Neurobiol; 2010 Jun; 91(2):102-7. PubMed ID: 20005916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biology of nerve injury in leprosy.
    Scollard DM
    Lepr Rev; 2008 Sep; 79(3):242-53. PubMed ID: 19009974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The armadillo as an animal model and reservoir host for Mycobacterium leprae.
    Balamayooran G; Pena M; Sharma R; Truman RW
    Clin Dermatol; 2015; 33(1):108-15. PubMed ID: 25432816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium leprae-induced demyelination: a model for early nerve degeneration.
    Rambukkana A
    Curr Opin Immunol; 2004 Aug; 16(4):511-8. PubMed ID: 15245748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of viable Mycobacterium leprae in soil samples: insights into possible sources of transmission of leprosy.
    Lavania M; Katoch K; Katoch VM; Gupta AK; Chauhan DS; Sharma R; Gandhi R; Chauhan V; Bansal G; Sachan P; Sachan S; Yadav VS; Jadhav R
    Infect Genet Evol; 2008 Sep; 8(5):627-31. PubMed ID: 18599381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corroboration of cross-reactivity between
    Pathak VK; Singh I; Singh SV; Sengupta U
    Front Microbiol; 2022; 13():1075053. PubMed ID: 36560940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response.
    Hernandez Mde O; Fulco Tde O; Pinheiro RO; Pereira Rde M; Redner P; Sarno EN; Lopes UG; Sampaio EP
    Eur J Pharmacol; 2011 Nov; 670(1):272-9. PubMed ID: 21925494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leprosy bug provides clues to early nerve degeneration.
    Lepr Rev; 2002 Dec; 73(4):402. PubMed ID: 12549849
    [No Abstract]   [Full Text] [Related]  

  • 40. Leprous neuropathy.
    de Freitas MR; Said G
    Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.